HC Andersen Capital Events 21/09: Meet the top management in NeoDynamics
HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.NEODYNAMICS – Q&A SESSION WITH CEO ANNA ERIKSRUDIn this Q&A session, we will focus on the FDA’s approval of NeoDynamics innovative pulse biopsy system NeoNavia™.The US market is potentially the largest and is estimated to reach $830 million by 2025.Feel free to ask questions during the presentation.NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing the diagnosis and care of breast cancer. The company’s